Clinical Trial Update: PK/PD Study of SHR-2017 Injection in Patients With Bone Metastases [Phase 1]

View source ↗

Summary

Phase 1 PK/PD study of SHR-2017 Injection in patients with bone metastases has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Metastases

Drugs mentioned

• SHR-2017 Injection (SHR-2017)

Snippet

Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Conditions: Patients With Bone Metastases | Phase 1 | Status: COMPLETED